186 studies on Mgf curated from PubMed, ClinicalTrials.gov, and EuropePMC. Updated daily.
Independent certificate-of-analysis evidence from third-party labs — the data behind the studies. Updated as new COAs are verified. Read the full grey-market analysis →
| Manufacturer | Batches | Avg purity | |
|---|---|---|---|
| Simple Peptide | 3 | 99.64% | View COA → |
| Alpha & Omega | 3 | 99.64% | View COA → |
Recent certificates: #15169 (99.491%) · #46295 (99.873%) · #24549 (99.493%) · #45764 (99.614%) · #60659 (99.25%) · #62569 (99.25%)
Manufacturers with published third-party certificates of analysis for Mgf. Open a vendor to see every batch we've verified.
This pioneering study represents a significant step towards a proactive and personalized approach to sarcopenia management, potentially transforming how this debilitating condition is diagnosed and treated globally. B…
The termination of this trial highlights the significant challenges in developing and testing combination therapies for complex conditions like IGF-1 deficiency and short stature. While this specific study did not yie…
Sandostatin LAR is a well-established treatment for acromegaly, and this study aimed to refine our understanding of its comprehensive benefits beyond just hormone suppression. Demonstrating clear improvements in metab…
This study is significant because it investigated the impact of very early initiation of growth hormone therapy in Turner Syndrome, a critical period for growth and development. The findings, once fully published, cou…
This study is significant because it explores the practical application of lanreotide Autogel 120 mg at extended dosing intervals, potentially offering a more convenient and less burdensome treatment schedule for pati…
The successful completion of this Phase 3 trial is a significant step towards developing an effective treatment for primary IGF-1 deficiency, a condition with limited therapeutic options. rhIGF-1 (mecasermin) holds su…
This pioneering single-patient study represents an early, crucial exploration into a novel therapeutic approach for a complex and rare genetic disease. Targeting low IGF-1 levels in Werner's Syndrome patients with ost…
This research highlights that serum IGF-1 could serve as a valuable biomarker for predicting the progression of anxiety in Parkinson's disease patients, potentially allowing for earlier intervention. Identifying patie…
This study represents a significant advancement in the management of pediatric growth hormone deficiency, offering a more convenient treatment regimen that could substantially improve patient adherence and quality of …
This Phase II trial is profoundly important because it seeks to identify a safer, more tolerable preventative strategy for breast cancer in high-risk post-menopausal women. Current preventative doses of Exemestane and…
The investigation of novel agents like CP-751,871 in combination with established chemotherapy is crucial for improving outcomes in advanced NSCLC, where new therapeutic strategies are desperately needed. Understandin…
This is a proceedings publication from the 49th Annual Meeting of the Austrian Society of Surgery, held in Innsbruck, May 21-23, 2008, guest-edited by Beate Neuhauser, Dietmar Öfner, Elfriede Ruttmann-Ulmer, and Anton…
Understanding the acute molecular response to muscle reloading is critical for optimizing rehabilitation protocols after periods of disuse. This study highlights that autophagy and myogenesis pathways are rapidly acti…
Accurate and reliable non-invasive prenatal screening for 22q11.2 deletion syndrome is crucial for early diagnosis and informed decision-making for expectant parents. The internal analytical verification of a targeted…
This research establishes IGF-1 deficiency as a crucial, previously underappreciated factor in the pathogenesis and prediction of Poor Ovarian Response. The findings suggest that routine screening for IGF-1 levels cou…
This study underscores the significant impact of modifiable lifestyle factors on IGF-1 levels and subsequent breast cancer risk, particularly within vulnerable populations like Palestinian women in the Gaza Strip. The…
This research highlights a novel mechanism by which diabetes exacerbates coronary artery disease, specifically through its detrimental effects on lymphatic vessel formation and function in the fat surrounding the hear…
This research identifies MLPH as a novel and potent regulator of human hair growth, acting directly on the critical IGF-1 signaling pathway within the dermal papilla. Understanding this mechanism provides a new therap…
This synthesis of evidence underscores the critical role of growth hormone (GH) in driving breast cancer progression, metastasis, and angiogenesis, moving beyond the traditional focus on steroid hormones. Understandin…
This research highlights a critical, previously underappreciated mechanism by which androgenic anabolic steroid (AAS) use may exert its adverse health effects. The disruption of the IGF-PAPP-A-stanniocalcin axis could…
This study represents a significant advancement in standardizing IGF-1 measurement, which is absolutely critical for accurate diagnosis and effective monitoring of endocrine disorders. The enhanced precision, accuracy…
This comprehensive review highlights the critical role of IGF-1 in MASLD pathogenesis, suggesting it's not just a correlative factor but potentially a key player. The most significant implication is that IGF-1 levels …
This study provides compelling evidence that combining BoNT-A with CIMT offers a synergistic approach to not only improve motor function but also actively promote skeletal muscle regeneration in hemiplegic cerebral pa…
Understanding how different exercise types acutely impact cerebral blood flow is crucial for developing targeted interventions to maintain cognitive function in healthy aging. If this study demonstrates significant im…
The development of effective and safe strategies for rapid weight loss in severe obesity is crucial for improving patient health and preparing for bariatric surgery or other long-term interventions. If the results of …
The establishment of accurate normative ranges for IGF-1, IGFBP-3, and ALS is profoundly important for pediatric endocrinology. These reference values provide clinicians with the necessary tools to differentiate betwe…
This global registry represents a crucial step in understanding the long-term safety and effectiveness of Increlex® for SPIGFD. By collecting data from a large, diverse patient population over many years, it can ident…
If successful, this research could provide a non-pharmacological strategy to mitigate breast cancer risk in individuals with BRCA mutations. Understanding the impact of diet on biomarkers like IGF-I could empower muta…
The demonstration of safety and feasibility for the Fasting Mimicking Diet (FMD) in cancer patients is a significant step, as it suggests that this non-pharmacological intervention could be safely integrated into exis…
This Phase 4 study is significant because it investigates a sequential therapy approach for Thyroid Associated Ophthalmopathies (TAO), a debilitating condition often resistant to current treatments. IBI311, as an anti…
Understanding the role of post-exercise protein in bone health could significantly impact recovery protocols for endurance runners and other athletes, potentially reducing the risk of stress fractures and osteoporosis…
Free, no account — handy when you're working with Mgf.